Disease ID | Disease name | Source of annotation with CCND1 | OMIM link | Number of associated genes | genes |
---|---|---|---|---|---|
193300 | VON HIPPEL-LINDAU SYNDROME | OMIM | link to OMIM | 2 | VHL, CCND1 |
254500 | MYELOMA, MULTIPLE | OMIM | link to OMIM | 2 | LIG4, CCND1 |
114500 | COLORECTAL CANCER | OMIM | link to OMIM | 30 | TLR4, RAD54B, PTPRJ, TP53, EP300, PTPN12, ODC1, FLCN, TLR2, BAX, PLA2G2A, AURKA, NRAS, APC, MCC, TRIM28, MLH3, AKT1, MT-CO1, AXIN2, CTNNB1, PDGFRL, PIK3CA, KAT5, DCC, BRAF, CCND1, FGFR3, DLC1, BUB1B |
Download the gene annotation in CSV format
KEGG pathway | KEGG ID | KEGG IC |
---|---|---|
Melanoma | hsa05218 | 6.56 |
Bladder cancer | hsa05219 | 7.38 |
FoxO signaling pathway | hsa04068 | 5.63 |
Pancreatic cancer | hsa05212 | 6.56 |
Endometrial cancer | hsa05213 | 6.81 |
Colorectal cancer | hsa05210 | 6.52 |
Thyroid cancer | hsa05216 | 7.48 |
Glioma | hsa05214 | 6.66 |
Jak-STAT signaling pathway | hsa04630 | 5.44 |
Focal adhesion | hsa04510 | 4.92 |
Oxytocin signaling pathway | hsa04921 | 5.4 |
Viral myocarditis | hsa05416 | 6.45 |
HTLV-I infection | hsa05166 | 4.59 |
Wnt signaling pathway | hsa04310 | 5.49 |
Hepatitis B | hsa05161 | 5.52 |
Measles | hsa05162 | 5.6 |
Proteoglycans in cancer | hsa05205 | 5.02 |
Cell cycle | hsa04110 | 5.68 |
MicroRNAs in cancer | hsa05206 | 5.38 |
Pathways in cancer | hsa05200 | 3.98 |
Viral carcinogenesis | hsa05203 | 5.08 |
p53 signaling pathway | hsa04115 | 6.56 |
Hippo signaling pathway | hsa04390 | 5.37 |
Prolactin signaling pathway | hsa04917 | 6.6 |
Acute myeloid leukemia | hsa05221 | 6.74 |
Chronic myeloid leukemia | hsa05220 | 6.48 |
Thyroid hormone signaling pathway | hsa04919 | 5.82 |
AMPK signaling pathway | hsa04152 | 5.8 |
PI3K-Akt signaling pathway | hsa04151 | 4.21 |
Prostate cancer | hsa05215 | 6.11 |
Non-small cell lung cancer | hsa05223 | 6.88 |
Small cell lung cancer | hsa05222 | 6.17 |
REACTOME pathway | REACTOME ID | REACTOME IC |
---|---|---|
Mitotic G1-G1/S phases | R-HSA-453279 | 5.91 |
G1 Phase | R-HSA-69236 | 7.73 |
Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 8.12 |
Signaling by NOTCH | R-HSA-157118 | 6.2 |
S Phase | R-HSA-69242 | 6.02 |
RMTs methylate histone arginines | R-HSA-3214858 | 7.49 |
Cell Cycle, Mitotic | R-HSA-69278 | 4.16 |
Chromatin organization | R-HSA-4839726 | 5.19 |
Cyclin D associated events in G1 | R-HSA-69231 | 7.73 |
Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 7.34 |
Cell Cycle | R-HSA-1640170 | 3.89 |
Pre-NOTCH Expression and Processing | R-HSA-1912422 | 7.49 |
Ubiquitin-dependent degradation of Cyclin D1 | R-HSA-69229 | 7.34 |
Signal Transduction | R-HSA-162582 | 1.78 |
Chromatin modifying enzymes | R-HSA-3247509 | 5.19 |
GO term | GO ID | GO IC |
---|---|---|
kinase regulator activity | GO:0019207 | 4.5 |
enzyme binding | GO:0019899 | 2.27 |
macromolecular complex binding | GO:0044877 | 2.61 |
binding | GO:0005488 | 0.18 |
molecular function regulator | GO:0098772 | 2.51 |
proline-rich region binding | GO:0070064 | 6.79 |
transcription corepressor activity | GO:0003714 | 4.33 |
transcription cofactor activity | GO:0003712 | 3.44 |
cyclin-dependent protein serine/threonine kinase regulator activity | GO:0016538 | 6.41 |
transferase activity | GO:0016740 | 1.95 |
transcription factor activity, transcription factor binding | GO:0000989 | 3.36 |
transcription factor activity, protein binding | GO:0000988 | 3.35 |
protein complex binding | GO:0032403 | 3.09 |
protein kinase activity | GO:0004672 | 3.27 |
histone deacetylase binding | GO:0042826 | 5.08 |
transcription factor binding | GO:0008134 | 3.46 |
protein kinase regulator activity | GO:0019887 | 4.6 |
enzyme regulator activity | GO:0030234 | 2.85 |
kinase activity | GO:0016301 | 2.93 |
protein kinase binding | GO:0019901 | 3.44 |
kinase binding | GO:0019900 | 3.32 |
catalytic activity | GO:0003824 | 1.05 |
phosphotransferase activity, alcohol group as acceptor | GO:0016773 | 3.08 |
transferase activity, transferring phosphorus-containing groups | GO:0016772 | 2.77 |
protein binding | GO:0005515 | 0.46 |